Table 1.
Baseline Characteristics
| Variables | Acute Group No. (%) Or Mean±SD | Chronic Group No. (%) Or Mean±SD | P-value |
|---|---|---|---|
| Age (years) | 59.13 ± 9.91 | 55.92 ± 12.06 | 0.451 |
| Male | 52 (82.5) | 18 (78.3) | 0.890 |
| Characteristics | |||
| Hypertension | 58 (92.1) | 20 (87.0) | 0.762 |
| Smoking | 41 (65.1) | 16 (69.6) | 0.697 |
| Uremia | 5 (7.9) | 3 (13.0) | 0.762 |
| Diabetes | 11 (17.5) | 4 (17.4) | 1 |
| COPD | 2 (3.2) | 2 (8.7) | 0.619 |
| Cardiac disease | 5 (7.9) | 1 (4.3) | 0.920 |
| Carotid disease | 2 (3.2) | 0 | 1 |
| Indications for TEVAR | |||
| Impending rupture | 17 (27.0) | 4 (17.4) | 0.977 |
| Organ malperfusion | 19 (30.2) | 2 (8.7) | 0.040 |
| Resistant hypertension | 15 (23.8) | 5 (21.7) | 0.841 |
| Refractory pain | 24 (38.1) | 8 (34.8) | 0.778 |
| Aortic growth | 4 (6.3) | 8 (34.8) | 0.003 |
Abbreviation: TEVAR, thoracic endovascular aortic repair.